Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-23T19:46:37.388Z Has data issue: false hasContentIssue false

Vestibular neuronitis in a child with coronavirus disease 2019 infection and review of the literature

Published online by Cambridge University Press:  16 November 2022

A Goulioumis*
Affiliation:
Department of Otorhinolaryngology, Karamandanio Children's Hospital, Patras, Greece
M Angelopoulou
Affiliation:
Department of Otorhinolaryngology, Karamandanio Children's Hospital, Patras, Greece
M Athanasopoulos
Affiliation:
Department of Otorhinolaryngology, University of Patras Medical School, Patras, Greece
K Kourelis
Affiliation:
Department of Otorhinolaryngology, Karamandanio Children's Hospital, Patras, Greece
*
Author for correspondence: Dr Anastasios Goulioumis, Erythrou Stavou 40, 26331 Patras, Greece E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Objective

This article presents the case of an adolescent with asymptomatic coronavirus disease 2019 infection who had vestibular neuronitis symptoms.

Method and results

The new coronavirus disease 2019 demonstrates neurotropic properties, apart from airway symptoms. Early in the pandemic, coronavirus disease 2019 infection had been associated with olfactory disturbances. Accumulative evidence supports that both the infection with coronavirus disease 2019 and the vaccination against the virus may induce a condition of vestibular hypofunction, known as vestibular neuronitis. Coronavirus disease 2019 may directly affect the vestibular organs and ganglia, or indirectly damage them via immune-mediated mechanisms. In most cases, complete recovery is achieved with the typical therapeutic approaches for vestibular neuronitis, consisting of supportive measures and corticosteroids.

Conclusion

Physicians may expect an increased incidence of vestibular neuronitis during the coronavirus disease 2019 pandemic. Conversely, coronavirus disease 2019 infection should be considered in patients with sudden vestibular symptoms.

Type
Clinical Records
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Introduction

The coronavirus disease 2019 (Covid-19) appeared as a pandemic in 2020; infected patients primarily presented with lower airway and lung symptoms.Reference Tsang, Chan, Cho, Yu, Yim and Chan1 Early data suggested that the new virus also has neurotropic properties that affect sensory epithelia, with olfactory epithelium damage reported in 33–68 per cent of cases.Reference Meng, Deng, Dai and Meng2 The labyrinth is another sensory organ that can be affected by neurotropic viruses.

A typical vestibular organ pathology characterised by peripheral type vertigo is vestibular neuronitis.Reference Jeong, Kim and Kim3 This condition usually constitutes permanent damage to the upper vestibular ganglion, commonly by reactivation of herpes simplex viruses that remain in the ganglia in a dormant condition. Vestibular neuronitis is accompanied by typical signs and symptoms compatible with unilateral vestibular hypofunction. Accumulating literature indicates that Covid-19 may also induce vestibular neuronitis.Reference Ekobena, Rothuizen, Bedussi, Guilcher, Meylan and Ceschi4Reference Cetin10

This article presents a case of vestibular neuronitis in a child who tested positive for Covid-19 infection. Additionally, we present a review of the literature.

Case report

Our patient was an adolescent, aged 13 years old, with no previous history of vertigo or other labyrinthine pathologies. He came to the emergency department of our hospital following an episode of dizziness of sudden onset that continued for 48 hours.

Physical examination revealed spontaneous left-sided nystagmus. According to Alexander's law, the nystagmus was more prominent with the left gaze position, characterising it as a first-degree nystagmus. Romberg and Unterberger's tests showed a body inclination toward the right side. The head thrust test that examines the vestibulo-ocular reflex was deficient with a turn of the head to the right side. The head-shaking test brought out nystagmus with the quick phase direction to the left. The patient's otoscopy findings and auditory acuity examined by tone audiometry were normal. A thorough physical examination of the cranial nerves did not reveal any significant concerns. The patient did not complain of headaches or any neurological symptoms. The patient's history and physical examination findings indicated hypofunction of the vestibular organs of the right labyrinth.

A typical rapid Covid-19 test, conducted as part of our hospital policy for patients examined in the emergency department, revealed a positive result. However, the patient did not demonstrate any signs or symptoms of viral airway infection.

The patient was admitted in light of the severity of his vertigo. He was given diazepam 5 mg and methylprednisolone 32 mg per day, per os. He was also examined by a neurologist, who confirmed the absence of central nervous pathology symptoms. After 48 hours, his subjective feeling of dizziness had improved, and he was discharged from the hospital with a prescription for steroids for 3 additional days. He was given advice for vestibular rehabilitation exercises and booked in for a new appointment for three weeks later. He was also scheduled for a brain, brainstem and cerebellopontine angle magnetic resonance imaging (MRI) scan.

During the re-examination, the patient stated that his symptoms had gradually improved. He did not refer to any subjective dizziness or unsteadiness. In the head thrust test, he demonstrated only mild signs of right labyrinth hypofunction. His MRI examination findings were unremarkable. A diagnosis of vestibular neuronitis was confirmed. We explained to the patient the nature of the disease, the possibility of the sensation of unsteadiness in challenging conditions of unbalance, and the increased possibility of future recurrent episodes of paroxysmal positional vertigo.

Discussion

Dizziness is a common symptom affecting about 8 per cent of Covid-19 positive patients.Reference Malayala, Mohan, Vasireddy and Atluri6 Nevertheless, not all studies support an increased incidence of co-existing vertigo and coronavirus infection.Reference Charpiot, Hautefort, Jourdaine, Lavielle, Levy and Poillon11 Among cases of vertigo, many fulfil the criteria of vestibular neuronitis.

  • Dizziness is common in coronavirus disease 2019 (Covid-19), affecting about 8 per cent of patients

  • The disease may directly damage nerves, intruding into them via the angiotensin receptor or damage them indirectly through the immune system's reaction

  • Evidence indicates that both Covid-19 infection and the vaccination may induce vestibular hypofunction, known as vestibular neuronitis

  • Most Covid-19 patients with vestibular neuronitis have been treated with supportive measures and corticosteroids

  • Vestibular neuronitis with Covid-19 infection may occur even in paediatrics, as in our case

  • Increased vestibular neuronitis during the Covid-19 pandemic is expected; conversely, Covid-19 should be considered in patients with sudden vestibular symptoms

As with other neurotropic viruses responsible for vestibular neuronitis, Covid-19 may directly damage the nerves, intruding into them via the angiotensin receptor,Reference Aghagoli, Gallo Marin, Katchur, Chaves-Sell, Asaad and Murphy12 or it may damage them indirectly through the immune system's reaction.Reference Aghagoli, Gallo Marin, Katchur, Chaves-Sell, Asaad and Murphy12 The latter assumption is also supported by the fact that vestibular symptoms have been described even after the Covid-19 vaccination, particularly with the Pfizer vaccine.Reference Jeong13,Reference Kamogashira, Funayama, Asakura and Ishimoto14 Again, the suggested pathophysiology of Covid-19 vaccine related vestibular neuronitis and Covid-19 infection includes the reactivation of latent viruses, like herpes zoster, local angiitis of the cochlear capillaries, and immunoglobulin G mediated autoimmune reaction against the vestibular nerve.Reference Jeong13 Retrospective studies show that vestibular symptoms may appear weeks after infection.Reference Malayala, Mohan, Vasireddy and Atluri6 However, in the case of immunisation, vestibular symptoms can appear even a few hours after the first dose of the vaccine, which could not be consistent with an autoimmune reaction.Reference Ekobena, Rothuizen, Bedussi, Guilcher, Meylan and Ceschi4 Other studies speculate that the virus may also affect the central nervous system, through haematogenous transmission or retrograde transmission via the peripheral nerves.Reference Kaliyappan, Chen and Krishnan Muthaiah5

Most Covid-19 patients with vestibular neuronitis have been treated with supportive measures and corticosteroids.Reference Malayala, Mohan, Vasireddy and Atluri6 This therapeutic approach does not differ from the protocols that already exist for vestibular neuronitis. It is unclear whether the steroids alter the effectiveness of the immunisation. The mean age of the patients referred to in the aforementioned study was about 50 years.Reference Malayala, Mohan, Vasireddy and Atluri6 Only one article similar to our study describes a paediatric patient with Covid-19 and vestibular neuronitis.Reference Giannantonio, Scorpecci, Montemurri and Marsella15 Of note, 60 per cent of Covid-19 patients with vestibular symptoms experience complete resolution of symptoms.Reference Ong and Cruz16 Of those who recovered, in two-thirds of cases the recovery occurred within two weeks of the onset, but the recovery period may have spanned a few days to six weeks.Reference Ong and Cruz16 In only 4.5 per cent of the cases, vertigo preceded the viral symptoms.Reference Ong and Cruz16 However, some Covid-19 positive patients with vertigo do not exhibit any airway symptoms, as in our case. Not all series included MRI in the diagnostic battery. Notably, one study showed that in 19 per cent of patients with coronavirus infection and vertigo symptoms, who underwent an MRI scan, another neurological pathology was revealed.Reference Bokhary, Chaudhry and Abidi17

Conclusion

Physicians may expect an increased incidence of vestibular neuronitis during the Covid-19 pandemic. Conversely, Covid-19 infection should be considered in patients with sudden vestibular symptoms. Solid statistical findings indicate that the two conditions can co-exist. Pathological findings for tissue samples obtained with molecular techniques are expected to illuminate the pathophysiology of coronavirus-related damage to the vestibular ganglia or neuroepithelium. Cumulative evidence indicates that vestibular neuronitis can be a side effect of the Covid-19 vaccination, revealing the need for ongoing surveillance regarding the safety of vaccines.

Competing interests

None declared

Footnotes

Dr A Goulioumis takes responsibility for the integrity of the content of the paper

References

Tsang, HF, Chan, LWC, Cho, WCS, Yu, ACS, Yim, AKY, Chan, AKC et al. An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies. Expert Rev Anti Infect Ther 2021;19:877–88CrossRefGoogle ScholarPubMed
Meng, X, Deng, Y, Dai, Z, Meng, Z. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol 2020;41:102581CrossRefGoogle ScholarPubMed
Jeong, SH, Kim, HJ, Kim, JS. Vestibular neuritis. Semin Neurol 2013;33:185–94CrossRefGoogle ScholarPubMed
Ekobena, P, Rothuizen, LE, Bedussi, F, Guilcher, P, Meylan, S, Ceschi, A et al. Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines. Int J Audiol 2022. Epub 2022 May 5CrossRefGoogle ScholarPubMed
Kaliyappan, K, Chen, YC, Krishnan Muthaiah, VP. Vestibular cochlear manifestations in COVID-19 cases. Front Neurol 2022;13:850337CrossRefGoogle ScholarPubMed
Malayala, SV, Mohan, G, Vasireddy, D, Atluri, P. A case series of vestibular symptoms in positive or suspected COVID-19 patients. Infez Med 2021;29:117–22Google ScholarPubMed
Halalau, A, Halalau, M, Carpenter, C, Abbas, AE, Sims, M. Vestibular neuritis caused by severe acute respiratory syndrome coronavirus 2 infection diagnosed by serology: case report. SAGE Open Med Case Rep 2021;9:2050313X211013261Google ScholarPubMed
Mat, Q, Noël, A, Loiselet, L, Tainmont, S, Chiesa-Estomba, CM, Lechien, JR. Vestibular neuritis as clinical presentation of COVID-19. Ear Nose Throat J 2021;11:145561321995021Google Scholar
Motawea, KR, Monib, FA. New onset vertigo after COVID-19 infection. A case report. Indian J Otolaryngol Head Neck Surg 2021. Epub 2021 Jul 4Google ScholarPubMed
Cetin, YS. Vestibular neuronitis associated with an adult male COVID-19 infection: a case report. J Pak Med Assoc 2022;72:354–6CrossRefGoogle ScholarPubMed
Charpiot, A, Hautefort, C, Jourdaine, C, Lavielle, J-P, Levy, D, Poillon, G et al. Study of the comorbidity between cases of acute peripheral vestibulopathies and COVID-19. Otol Neurotol 2021;42:e1072–6CrossRefGoogle ScholarPubMed
Aghagoli, G, Gallo Marin, B, Katchur, NJ, Chaves-Sell, F, Asaad, WF, Murphy, SA. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care 2021;34:1062–71CrossRefGoogle ScholarPubMed
Jeong, J. Vestibular neuritis after COVID-19 vaccination. Hum Vaccin Immunother 2021;17:5126–8CrossRefGoogle ScholarPubMed
Kamogashira, T, Funayama, H, Asakura, S, Ishimoto, S. Vestibular neuritis following COVID-19 vaccination: a retrospective study. Cureus 2022;14:e24277Google ScholarPubMed
Giannantonio, S, Scorpecci, A, Montemurri, B, Marsella, P. Case of COVID-19-induced vestibular neuritis in a child. BMJ Case Rep 2021;14:e242978CrossRefGoogle ScholarPubMed
Ong, KMC, Cruz, TLG. Otologic and vestibular symptoms in COVID-19: a scoping review. World J Otorhinolaryngol Head Neck Surg 2022. Epub 2022 Apr 6CrossRefGoogle ScholarPubMed
Bokhary, H, Chaudhry, S, Abidi, SMR. Labyrinthitis: a rare consequence of COVID-19 infection. Cureus 2021;13:e17121Google ScholarPubMed